News for Research Frontiers Incorporated (REFR)

Research Frontiers Incorporated (NASDAQ:REFR) Q4 2024 Earnings Conference Call March 6, 2025 4:30 PM ETCompany ParticipantsJoe Harary - President &...

Research Frontiers Incorporated (NASDAQ:REFR) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsJoe Harary - President and...

WOODBURY, N.Y., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its third quarter of 2024....

WOODBURY, N.Y., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its second quarter of 2024....

Research Frontiers director buys $3,880 in company stock

This week at the Aircraft Interiors Expo in Hamburg, Germany, visitors to Gauzy's booth #6E120 are being treated to a broad array of innovative large aircraft solutions using Research...

WOODBURY, N.Y., May 09, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its first quarter of 2024....

Operator: Good afternoon, ladies and gentlemen. Welcome to Research Frontiers Investor Conference Call to discuss the Fourth Quarter and Full Year 2023 Results of operations and recent developments.

Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.

Research Frontiers Incorporated (NASDAQ:NASDAQ:REFR) Q4 2023 Earnings Conference Call March 7, 2024 4:30 PM ETCompany ParticipantsJoe Harary – President and...

WOODBURY, N.Y., March 07, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its fourth quarter and...

The Dow Jones index closed higher by around 50 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Gainers IVERIC bio, Inc. (NASDAQ:ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its ...